Ionis Pharmaceuticals (IONS) Change in Account Payables (2013 - 2026)

Ionis Pharmaceuticals' Change in Account Payables history runs 14 years deep, the most recent figure standing at -$3.1 million for Q1 2026.

• In Q1 2026, Change in Account Payables rose 88.08% year-over-year to -$3.1 million; the TTM figure through Mar 2026 stood at $7.5 million (up 174.85% YoY), while the FY2025 annual figure was -$15.4 million, down 196.06% from the prior year.
• Change in Account Payables was -$3.1 million for Q1 2026 at Ionis Pharmaceuticals, down from $13.8 million in the prior quarter.
• In the past five years, Change in Account Payables ranged from a high of $35.2 million in Q4 2024 to a low of -$26.0 million in Q1 2025.
• Historically, Change in Account Payables has averaged $396941.2 across 5 years, with a median of -$2.2 million in 2024.
• The sharpest annual moves came in 2023 and 2025: Change in Account Payables jumped 556.04% in 2023, then slumped 44113.56% in 2025.
• A 5-year view of Change in Account Payables shows it stood at -$4.5 million in 2022, then surged by 556.04% to $20.6 million in 2023, then surged by 71.06% to $35.2 million in 2024, then sank by 60.93% to $13.8 million in 2025, then slumped by 122.5% to -$3.1 million in 2026.
• The last three Change in Account Payables figures came in at -$3.1 million (Q1 2026), $13.8 million (Q4 2025), and -$8.8 million (Q3 2025), per Business Quant data.